معرفی
Dr. James Robert Falconer is a Senior Lecturer in the School of Pharmacy and Pharmaceutical Sciences at The University of Queensland (UQ), part of the Faculty of Health, Medicine and Behavioural Sciences. He has been at UQ since June 2015, following roles as an Assistant Lecturer and Research & Teaching Fellow at the University of Auckland (2011–2015). His academic journey includes a PhD (2007–2011) under Professors Jingyuan Wen and Raid Alany at the University of Auckland, focusing on supercritical fluid technology for transdermal drug delivery. He also holds a BSc in Genetics (1999), a Master's in Bioethics (2003), and a BPharm (Hons) (2005).
Research interests center on supercritical fluid applications for selective extraction, nanoparticulate drug delivery systems, and sustainable solvent processing. Key focus areas include green technology for organic solvent replacement, CO₂ repurposing, and advanced formulation technologies for antimicrobial agents. His work bridges pharmaceutical science, nanotechnology, and environmental sustainability.
Publications highlight innovations in supercritical CO₂ extraction of cannabinoids, psilocybin, and bioactives, alongside advancements in nanocarrier systems for drug delivery. Recent studies emphasize nose-to-brain delivery of antipsychotics, antimicrobial nanomaterials, and optimizing transdermal NSAID delivery.
Supervision & Grants: Dr. Falconer actively supervises PhD students across topics like psychedelic drug extraction, antimicrobial formulations, and cannabinoid processing. He has secured grants including a 2020–2021 project on cardiac medication stability and a 2017 grant for supercritical fluid-based antibiotic nanoparticles.
Labs/Teams: Collaborations include work with Argenta Global (veterinary formulations), the HaBS-Med Collaborative, and interdisciplinary teams at UQ focusing on nanomedicine and drug delivery systems.
